Six cycles of adjuvant anthracycline-taxane-based chemotherapy compared with eight cycles for women with breast cancer.

被引：0
|
作者：
Lee, Michael
Wilson, Sheridan
Porter, David James
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] Auckland Canc & Blood Ctr, Auckland, New Zealand
[3] Auckland City Hosp, Dept Oncol, Auckland, New Zealand
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e12045
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12045
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Palliative chemotherapy with vinorelbine or capecitabine in women with anthracycline and taxane refractory metastatic breast cancer.
    Clemons, MJ
    Verma, S
    Leung, V
    Dranitsaris, G
    Shalaby, I
    Oldfield, S
    Charbonneau, F
    Giotis, A
    Petrella, T
    Trudeau, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
  • [2] Comparison of four cycles epirubicin and cyclophosphamide (EC) followed by four cycles docetaxel (T) versus six cycles docetaxel and carboplatin (TP) as adjuvant chemotherapy for women with operable triple negative breast cancer.
    Yuan, Peng
    Du, Feng
    Wang, Jiayu
    Ma, Fei
    Fan, Ying
    Xu, Binghe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer
    Xu, Lu
    Che, Xiaofang
    Wu, Ying
    Song, Na
    Shi, Sha
    Wang, Shuo
    Li, Ce
    Zhang, Lingyun
    Zhang, Xinlian
    Qu, Xiujuan
    Teng, Yuee
    [J]. ONCOLOGY REPORTS, 2018, 39 (05) : 2315 - 2323
  • [4] Tumor-infiltrating lymphocytes to predict survival to anthracycline/taxane-based adjuvant chemotherapy in triple negative breast cancer.
    Ou, Qiyun
    Yu, Yunfang
    Xiao, Xiaoyun
    Luo, Baoming
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [5] Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
    Chen, Wanjing
    Tu, Qian
    Shen, Yanfei
    Tang, Kejun
    Hong, Mengying
    Shen, Yong
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)
  • [6] Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
    Wanjing Chen
    Qian Tu
    Yanfei Shen
    Kejun Tang
    Mengying Hong
    Yong Shen
    [J]. World Journal of Surgical Oncology, 19
  • [7] Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial
    Camara, Rafael J. A.
    Schwentner, Lukas
    Friedl, Thomas W. P.
    Deniz, Miriam
    Fink, Visnja
    Lato, Krisztian
    Widschwendter, Peter
    Rack, Brigitte
    Janni, Wolfgang
    Singer, Susanne
    Bekes, Inga
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (03) : 627 - 635
  • [8] Quality of life during and after adjuvant anthracycline-taxane-based chemotherapy with or without Gemcitabine in high-risk early breast cancer: results of the SUCCESS A trial
    Rafael J. A. Cámara
    Lukas Schwentner
    Thomas W. P. Friedl
    Miriam Deniz
    Visnja Fink
    Krisztian Lato
    Peter Widschwendter
    Brigitte Rack
    Wolfgang Janni
    Susanne Singer
    Inga Bekes
    [J]. Breast Cancer Research and Treatment, 2019, 175 : 627 - 635
  • [9] Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
    Huober, Jens
    von Minckwitz, Gunter
    Denkert, Carsten
    Tesch, Hans
    Weiss, Erich
    Zahm, Dirk Michael
    Belau, Antje
    Khandan, Fariba
    Hauschild, Maik
    Thomssen, Christoph
    Hoegel, Bernhard
    Darb-Esfahani, Silvia
    Mehta, Keyur
    Loibl, Sibylle
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2010, 124 (01) : 133 - 140
  • [10] Late cardiotoxicity in patients with breast cancer after taxane/anthracycline-based neoadjuvant and adjuvant chemotherapy
    Koroleva, I.
    Kopp, M. V.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345